Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Oryzon Genomics SA (DE:ORN)
FRANKFURT:ORN
Oryzon Genomics SA (ORN) Stock Price & Analysis
0 Followers
ORN Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€1.58 - €2.19
Previous Close€1.89
Volume0.00
Average Volume (3M)1.27K
Market Cap
€121.69M
Enterprise Value€117.81M
Total Cash (Recent Filing)€21.32M
Total Debt (Recent Filing)€17.44M
Price to Earnings (P/E)―
Beta0.06
Next Earnings
Jul 24, 2024EPS Estimate
>-€0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume1,273
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€7.25Price Target Upside284.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Oryzon Genomics SA News
PremiumCompany Announcements
Oryzon Genomics Bonds Converted to Shares
PremiumCompany Announcements
Oryzon Genomics Expands Capital with New SharesPremiumCompany Announcements
Oryzon Genomics Shareholders Approve Capital Boost
PremiumCompany Announcements
Oryzon Genomics Finalizes Capital Increase
PremiumCompany Announcements
Oryzon Genomics Announces Capital Increase and New SharesOptions Prices
Currently, No data available
---
Ownership Overview
11.01% Insiders
0.04% Mutual Funds
0.22% Other Institutional Investors
88.73% Public Companies and
Individual Investors
ORN FAQ
What was Oryzon Genomics SA’s price range in the past 12 months?
Oryzon Genomics SA lowest stock price was €1.58 and its highest was €2.19 in the past 12 months.
What is Oryzon Genomics SA’s market cap?
Currently, no data Available
When is Oryzon Genomics SA’s upcoming earnings report date?
Oryzon Genomics SA’s upcoming earnings report date is Jul 24, 2024 which is in 2 days.
How were Oryzon Genomics SA’s earnings last quarter?
Oryzon Genomics SA released its earnings results on May 06, 2024. The company reported -€0.019 earnings per share for the quarter, beating the consensus estimate of -€0.028 by €0.009.
Is Oryzon Genomics SA overvalued?
According to Wall Street analysts Oryzon Genomics SA’s price is currently Undervalued.
Does Oryzon Genomics SA pay dividends?
Oryzon Genomics SA does not currently pay dividends.
What is Oryzon Genomics SA’s EPS estimate?
Oryzon Genomics SA’s EPS estimate is >-€0.01.
How many shares outstanding does Oryzon Genomics SA have?
Oryzon Genomics SA has 64,011,856 shares outstanding.
What happened to Oryzon Genomics SA’s price movement after its last earnings report?
Oryzon Genomics SA reported an EPS of -€0.019 in its last earnings report, beating expectations of -€0.028. Following the earnings report the stock price went up 1.064%.
Which hedge fund is a major shareholder of Oryzon Genomics SA?
Currently, no hedge funds are holding shares in DE:ORN
---
Oryzon Genomics SA Stock Smart Score
Company Description
Oryzon Genomics SA
Oryzon Genomics SA is a clinical stage biopharmaceutical company and engaged in the development of epigenetics-based therapeutics. It is engaged in the field of epigenetic medicine and in the development of therapeutic, biological solutions for cancer and neurodegenerative diseases.
---
ORN Stock 12 Month Forecast
Average Price Target
€7.25
▲(284.00% Upside)
Technical Analysis
Best Analysts Covering ORN
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-1.80%
reiterated a buy rating last month
Copying Jonathan Aschoff's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -1.80% per trade.
---